Azelastine PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering a Azelastine PCD pharma franchise across India. Our portfolio spans 4 Azelastine formulations in Eye Drops and Nasal Spray forms, backed by consistent quality and monopoly-based distribution rights for our franchise partners.

What is Azelastine?

Azelastine is a topical second-generation antihistamine that blocks H1 receptors and also stabilises mast cells, quickly relieving allergic symptoms at the site of application while causing little of the drowsiness seen with oral antihistamines. It is formulated as a nasal spray and as ophthalmic drops. Its profile is documented on PubChem.

Therapeutic Applications

Azelastine nasal spray is used for seasonal and perennial allergic rhinitis and vasomotor rhinitis, while the eye drops relieve allergic conjunctivitis and itchy, watery eyes. It is prescribed by ENT surgeons, ophthalmologists, allergists and general physicians, and is often combined with a nasal steroid such as fluticasone.

Why Azelastine is a High-Potential Molecule for Distributors

Allergic rhinitis and conjunctivitis affect a large and rising share of the urban Indian population thanks to pollution and changing climate, driving strong, largely seasonal demand for topical allergy therapy. Azelastine's fast local action and low sedation give it a clear edge over oral antihistamines, and azelastine-fluticasone nasal combinations command premium pricing. Its focus on ophthal and ENT channels lets a distributor build a targeted, less-crowded specialty niche.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district and state-wise monopoly rights, WHO-GMP certified and DCGI-approved manufacturing, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent supply and billing model helps you build a profitable, protected business in your territory.

References

1. PubChem — Azelastine
2. MedlinePlus — Allergy
3. PubMed — Azelastine literature